HIV Vaccine Trials Network opens South African lab as it gears up to launch
Oct. 21, 2013
| Deborah Bach / Fred Hutch News Service
Hutch is opened a state-of-the art vaccine lab in Cape Town as it gears up to launch HIV vaccine trials there. The lab will analyze trial participants’ blood samples and study how their immune systems interact with the vaccine and with the virus.
Center's HIV Vaccine Trials Network and HIV research unit mark annual observance
May 17, 2012
Friday, May 18 is HIV Vaccine Awareness Day—time to reflect on the progress made in HIV prevention research and treatment and look ahead at ways of increasing community awareness and support.
As the home to the HIV Vaccine Trials Network (HVTN)—the largest clinical trials network for an HIV vaccine in the world—and the Statistical Center for HIV/AIDS Research and Prevention (SCHARP), the Hutchinson Center is on the frontline of the global fight to find a preventive vaccine against HIV.
Newsletter highlights clinical trial research, protocols in the field and the network's mission to drive the development of a safe, globally effective vaccine to prevent HIV
Sept. 12, 2011
This month, the HIV Vaccine Trials Network is reintroducing the HVTNews. The publication will highlight the progress of this international collaboration of scientists and educators who are searching for an effective and safe HIV vaccine.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.